1. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008;78(1):93-100.
2. Braunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Med. 2019;7:2050312119843700. [
DOI:10.1177/2050312119843700] [
PMID] [
PMCID]
3. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24-43.
https://doi.org/10.1161/HYPERTENSIONAHA.113.01833 [
DOI:10.1161/HYPERTENSIONAHA.117.10803]
4. Ye C, Ruan Y, Zou L, Li G, Li C, Chen Y, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes. PloS One. 2014;9(6):e100180. [
DOI:10.1371/journal.pone.0100180] [
PMID] [
PMCID]
5. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41(3):437-45. [
DOI:10.1161/01.HYP.0000054981.03589.E9] [
PMID]
6. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2008;2(6):484-94. [
DOI:10.1016/j.jash.2008.10.001] [
PMID]
7. Campbell SK, Lynch J, Esterman A, McDermott R. Pre-pregnancy predictors of hypertension in pregnancy among Aboriginal and Torres Strait Islander women in north Queensland, Australia; a prospective cohort study. BMC Public Health. 2013;13(1):1-9. [
DOI:10.1186/1471-2458-13-138] [
PMID] [
PMCID]
8. Munde S, Hazari N, Thorat A, Gaikwad S, Hatolkar V. Gamma glutamyl transferase and Lactate dehydrogenase as biochemical markers of severity of preeclampsia. Int J Med Healt Biomed Bioengineering Pharm Eng. 2014;8(1):50-3.
9. Fazal RS, Chandru S, Biswas M. Evaluation of total LDH and its isoenzymes as markers in preeclampsia. J Med Biochem. 2019;39(3):392-8. [
DOI:10.2478/jomb-2019-0045] [
PMID] [
PMCID]
10. Leeman L, Dresang LT, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2016;93(2):121-7.
11. Townsend R, O'Brien P, Khalil A. Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control. 2016;9:79. [
DOI:10.2147/IBPC.S77344] [
PMID] [
PMCID]
12. Saxena S, Srivastava PC, Thimmaraju K, Mallick AK, Dalmia K, Das B. Socio-demographic profile of pregnancy induced hypertension in a tertiary care centre. Sch J Appl Med Sci. 2014;2(6D):3081-6.
13. Bhave NV, Shah PK. A correlation of lactate dehydrogenase enzyme levels in pregnancy induced hypertensive disorders with severity of disease, maternal and perinatal outcomes. Int J Reprod Contracept Obstet Gynecol. 2017;6(10):4302-8. [
DOI:10.18203/2320-1770.ijrcog20174132]
14. Popovski N, Nikolov A. Practice Bulletin of the American College of Obstetrics and Gynaecologists 2019 on Magement of Hypertensive Disorders in Pregnancy-A Short Review of the Current Recommendations. Biomed J Sci Technol Res. 2019;23(2):17198-201. [
DOI:10.26717/BJSTR.2019.23.003861]
15. Mehta M, Parashar M, Kumar R. Serum lactate dehydrogenase: a prognostic factor in pre-eclampsia. Int J Reprod Contracept Obstet Gynecol. 2019;8(7). [
DOI:10.18203/2320-1770.ijrcog20193044]
16. Mason JE, Starke RD, Van Kirk JE. Gamma‐Glutamyl transferase: a novel cardiovascular risk BioMarker. Prev Cardiol. 2010;13(1):36-41. [
DOI:10.1111/j.1751-7141.2009.00054.x] [
PMID]
17. Wu J, Zhou W, Li Q, Yuan R, Li H, Cui S. Combined use of serum gamma glutamyl transferase level and ultrasonography improves prediction of perinatal outcomes associated with preeclamptic pregnancy. Clin Chim Acta. 2017;475:97-101.
https://doi.org/10.1016/j.aca.2017.01.015 [
DOI:10.1016/j.cca.2017.09.018]
18. Fornaciari I, Fierabracci V, Corti A, Aziz Elawadi H, Lorenzini E, Emdin M, et al. Gamma-glutamyltransferase fractions in human plasma and bile: characteristic and biogenesis. PLoS One. 2014;9(2):e88532. [
DOI:10.1371/journal.pone.0088532] [
PMID] [
PMCID]
19. Balakrishna S, Prabhune AA. Gamma-glutamyl transferases: A structural, mechanistic and physiological perspective. Front Biol. 2014;9(1):51-65. [
DOI:10.1007/s11515-014-1288-0]
20. Patil RR, Choudhari AS. Evaluation of Activities of Serum Gamma Glutamyl Transferase and Adenosine Deaminase in Pre-Eclampsia-A Case Control Study. J Med Res. 2016;6(4):313-5.
21. Nosrat BS, Azarhoosh R, Borghei A, Sedaghati M, Besharat S, Ghaemi E. Serum level of Lactate dehydrogenase, Homocystein, Hemoglobin and platelet in preeclampsia. Pak J Med Sci. 2011;27(5):1014-7.
22. Gruccio S, Di Carlo MB, Pandolfo M, Santa Cruz G, Touzon MS, Negri G, et al. Biochemical profiling study in umbilical cord blood as predictors of neonatal damage. Int J Clin Pediatr. 2014;3(1):5-11. [
DOI:10.14740/ijcp140e]
23. Qublan H, Ammarin V, Bataineh O, Al-Shraideh Z, Tahat Y, Awamleh I, et al. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia. Med Sci Monit. 2005;11(8):CR393-CR7.
24. Afroz R, Akhter QS, Sadia H, Sultana S. Serum Lactate Dehydrogenase (LDH) level in severe preeclampsia. J Bangladesh Soc physiol. 2015;10(2):71-5. [
DOI:10.3329/jbsp.v10i2.27168]
25. Andrews L, Patel N. Correlation of serum lactate dehydrogenase and pregnancy induced hypertension with its adverse outcomes. Int J Res Med Sci. 2016;4(5):1347-50. [
DOI:10.18203/2320-6012.ijrms20161112]
26. Shojaei K, Jafari RM, Haghighat F. Comparison of the Level of Uric Acid and LDH in Mothers in Early and Late Preeclampsia and Determination of Its Association with the Severity of Preeclampsia. J Biochem Tech. 2019;2:36-8.
27. Umasatyasri Y, Vani I, Shamita P. Role of LDH (Lactate dehydrogenase) in preeclampsia-eclampsia as a prognostic marker: An observational study. IAIM. 2015;2(9):88-93.
28. Kasraeian M, Asadi N, Vafaei H, Zamanpour T, Shahraki HR, Bazrafshan K. Evaluation of serum biomarkers for detection of preeclampsia severity in pregnant women. Pak J Med Sci. 2018;34(4):869. [
DOI:10.12669/pjms.344.14393] [
PMID] [
PMCID]
29. Jaiswar S, Gupta A, Sachan R, Natu S, Shaili M. Lactic dehydrogenase: a biochemical marker for preeclampsia-eclampsia. J Obstet Gynaecol India. 2011;61(6):645-8. [
DOI:10.1007/s13224-011-0093-9] [
PMID] [
PMCID]
30. Vanishree B, Dayanand C, Sheela S. Can GGT and LDH be indicators of endothelial vascular damage in Preeclampsia? Int J Clin Biochem Res. 2019;6(4):571-4. [
DOI:10.18231/j.ijcbr.2019.118]
31. Sarkar PD, Sogani S. Evaluation of serum lactate dehydrogenase and gamma glutamyl transferase in preeclamptic pregnancy and its comparison with normal pregnancy in third trimester. Int J Res Med Sci. 2013;1(4):365-8.
32. Elias SES, Eltom A, Osman AL, Babker AM. Gamma glutamyl transferase and lactate dehydrogenase as biochemical markers of severity of preeclampsia among Sudanese pregnant women. Int J Reprod Contracept Obstet Gynecol. 2018;7(8):3020-3. [
DOI:10.18203/2320-1770.ijrcog20183294]
33. Kulkarni VV, Shaikh B. To Study Levels of LDH in Normal Pregnancy, Pre-Eclampsia & Eclampsia. J Evol Med Dent Sci. 2019;8(35):2768-73. [
DOI:10.14260/jemds/2019/600]
34. Dave A, Maru L, Jain A. LDH (lactate dehydrogenase): a biochemical marker for the prediction of adverse outcomes in pre-eclampsia and eclampsia. J Obstet Gynaecol India. 2016;66(1):23-9. [
DOI:10.1007/s13224-014-0645-x] [
PMID] [
PMCID]
35. Sumathi M, Joshi RU, Gomathy E, Shashidhar K. Usefulness of serum gamma glutamyl transferase in assessing severity of preeclampsia. Int J Clin Biochem Res. 2016;3(2):245-9. [
DOI:10.5958/2394-6377.2016.00047.2]
36. Dev SV, Hemalatha C. Evaluation of lactate dehydrogenase-a biochemical marker of preeclampsia. J Evol Med Dent Sci. 2017;6(79):5572-5. [
DOI:10.14260/jemds/2017/1209]
37. Talwar P, Kondareddy T, Shree P. LDH as a prognostic marker in hypertensive pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;6(6):2444-6. [
DOI:10.18203/2320-1770.ijrcog20172328]